MedPath
FDA Approval

Phenytoin

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
June 28, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Phenytoin(50 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Taro Pharmaceutical Industries Ltd.

Taro Pharmaceuticals U.S.A., Inc

600072078

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Phenytoin

Product Details

NDC Product Code
51672-4146
Application Number
ANDA200565
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 28, 2022
Lactose monohydrateInactive
Code: EWQ57Q8I5XClass: IACT
PhenytoinActive
Code: 6158TKW0C5Class: ACTIBQuantity: 50 mg in 1 1
D&C Yellow No. 10Inactive
Code: 35SW5USQ3GClass: IACT
Saccharin sodiumInactive
Code: SB8ZUX40TYClass: IACT
aluminum oxideInactive
Code: LMI26O6933Class: IACT
TalcInactive
Code: 7SEV7J4R1UClass: IACT
Magnesium StearateInactive
Code: 70097M6I30Class: IACT
FD&C Yellow No. 6Inactive
Code: H77VEI93A8Class: IACT
SucroseInactive
Code: C151H8M554Class: IACT
Hypromellose, UnspecifiedInactive
Code: 3NXW29V3WOClass: IACT
© Copyright 2025. All Rights Reserved by MedPath